Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13802)
All Articles published online
|
Publishing Process of This Article
|
Mar 14, 2014 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ghoshal UC, Srivastava D. Irritable bowel syndrome and small intestinal bacterial overgrowth: Meaningful association or unnecessary hype. World J Gastroenterol 2014; 20(10): 2482-2491 [PMID: 24627585 DOI: 10.3748/wjg.v20.i10.2482] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i10/2482.htm |
| Number | Citing Articles |
| 1 |
Kien Nguyen, Chu Manh Hung, Trinh Minh Ngoc, Dang Thi Thanh Le, Duc Hoa Nguyen, Duy Nguyen Van, Hieu Nguyen Van. Low-temperature prototype hydrogen sensors using Pd-decorated SnO2 nanowires for exhaled breath applications. Sensors and Actuators B: Chemical 2017; 253: 156 doi: 10.1016/j.snb.2017.06.141
|
| 2 |
Humayra Dervin, Natalia Zarate‐Lopez, Rami Sweis, Alexia Mensah, Konstantinos Fragkos, Concetta Brugaletta, Amanda Raeburn, Anton Emmanuel. Low prevalence of positive hydrogen breath tests in patients with functional gastrointestinal conditions and hypermobile Ehlers–Danlos syndrome. Neurogastroenterology & Motility 2023; 35(9) doi: 10.1111/nmo.14570
|
| 3 |
Angeles Pérez Aisa, Mari Carmen García Gavilán, Julia Alcaide García, Isabel María Méndez Sánchez, Robin Rivera Irigoin, Francisco Fernández Cano, Teresa Pereda Salguero, Francisco Rivas Ruiz. Small intestinal bacterial overgrowth is common after gastrectomy but with little impact on nutritional status. Gastroenterología y Hepatología (English Edition) 2019; 42(1): 1 doi: 10.1016/j.gastre.2019.01.007
|
| 4 |
Xiufang Cui, Haiyang Wang, Ziping Ye, Yi Li, Xinyun Qiu, Hongjie Zhang. Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02015-w
|
| 5 |
G. Losurdo, A. Marra, E. Shahini, B. Girardi, F. Giorgio, A. Amoruso, A. Pisani, D. Piscitelli, M. Barone, M. Principi, A. Di Leo, E. Ierardi. Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled‐data analysis. Neurogastroenterology & Motility 2017; 29(6) doi: 10.1111/nmo.13028
|
| 6 |
Stephen D. H. Malnick, Sheral Ohayon Michael. The Intestinal Microbiome and the Metabolic Syndrome—How Its Manipulation May Affect Metabolic-Associated Fatty Liver Disease (MAFLD). Current Issues in Molecular Biology 2023; 45(9): 7197 doi: 10.3390/cimb45090455
|
| 7 |
Hani Essa, Shaheen Hamdy, Darren Green, Simon Lal, John McLaughlin, Sandra Hoffmann, Eugena Leitao, Peter Paine. Hydrogen and methane breath test results are negatively associated with IBS and may reflect transit time in post‐surgical patients. Neurogastroenterology & Motility 2021; 33(6) doi: 10.1111/nmo.14033
|
| 8 |
Roberta Poceviciute, Said R. Bogatyrev, Anna E. Romano, Amanda H. Dilmore, Octavio Mondragón-Palomino, Heli Takko, Ojas Pradhan, Rustem F. Ismagilov. Quantitative whole-tissue 3D imaging reveals bacteria in close association with mouse jejunum mucosa. npj Biofilms and Microbiomes 2023; 9(1) doi: 10.1038/s41522-023-00423-2
|
| 9 |
Michael Camilleri, David A. Katzka. Enhancing High Value Care in Gastroenterology Practice. Clinical Gastroenterology and Hepatology 2016; 14(10): 1376 doi: 10.1016/j.cgh.2016.05.022
|
| 10 |
Dong Woo Shin, Hyuk Yoon, Hyun Soo Kim, Yoon Jin Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee. Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study. Evidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/9147914
|
| 11 |
Uday C. Ghoshal, Ujjala Ghoshal. Clinical and Basic Neurogastroenterology and Motility. 2020; : 359 doi: 10.1016/B978-0-12-813037-7.00025-X
|
| 12 |
Uday C. Ghoshal, Ujjala Ghoshal. Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders. Gastroenterology Clinics of North America 2017; 46(1): 103 doi: 10.1016/j.gtc.2016.09.008
|
| 13 |
Uday C Ghoshal, Ujjala Ghoshal, Ayesha Shah, Gerald Holtmann. Evaluation of small intestinal bacterial overgrowth. Expert Review of Gastroenterology & Hepatology 2023; 17(5): 461 doi: 10.1080/17474124.2023.2207008
|
| 14 |
Kok Ann Gwee, Sutep Gonlachanvit, Uday C Ghoshal, Andrew S B Chua, Hiroto Miwa, Justin Wu, Young-Tae Bak, Oh Young Lee, Ching-Liang Lu, Hyojin Park, Minhu Chen, Ari F Syam, Philip Abraham, Jose Sollano, Chi-Sen Chang, Hidekazu Suzuki, Xiucai Fang, Shin Fukudo, Myung-Gyu Choi, Xiaohua Hou, Michio Hongo. Second Asian Consensus on Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 2019; 25(3): 343 doi: 10.5056/jnm19041
|
| 15 |
Emily K Stern, Darren M Brenner. Gut Microbiota-Based Therapies for Irritable Bowel Syndrome. Clinical and Translational Gastroenterology 2018; 9(2): e134 doi: 10.1038/ctg.2018.2
|
| 16 |
Yoshiharu Uno. Pilot Study on Gas Patterns of Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth Following Ingestion of Lactulose. Open Journal of Gastroenterology 2015; 5(11): 155 doi: 10.4236/ojgas.2015.511025
|
| 17 |
Uday C. Ghoshal, Ratnakar Shukla, Ujjala Ghoshal. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut and Liver 2017; 11(2): 196 doi: 10.5009/gnl16126
|
| 18 |
LA Costa, TNF Gomes, CU Braga, L Lenz, SJ Miszputen, O Ambrogini. Irritable bowel syndrome and small intestinal bacterial overgrowth: Assessment with breath test. Archives of Clinical Gastroenterology 2020; : 041 doi: 10.17352/2455-2283.000077
|
| 19 |
Angeles Pérez Aisa, Mari Carmen García Gavilán, Julia Alcaide García, Isabel María Méndez Sánchez, Robin Rivera Irigoin, Francisco Fernández Cano, Teresa Pereda Salguero, Francisco Rivas Ruiz. El sobrecrecimiento bacteriano de intestino delgado es una entidad frecuente tras gastrectomía, pero con escasa relevancia en el estado nutricional. Gastroenterología y Hepatología 2019; 42(1): 1 doi: 10.1016/j.gastrohep.2018.07.001
|
| 20 |
Binrui Chen, Shuwen Zhu, Lijun Du, Huiqin He, John J. Kim, Ning Dai. Reduced interstitial cells of Cajal and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model. Scandinavian Journal of Gastroenterology 2017; 52(10): 1065 doi: 10.1080/00365521.2017.1342141
|
| 21 |
C. Bucci, A. Santonicola, P. Iovino. Probiotics, Prebiotics, and Synbiotics. 2016; : 557 doi: 10.1016/B978-0-12-802189-7.00040-X
|
| 22 |
Stephen D. H. Malnick, David Fisher, Marina Somin, Manuela G. Neuman. Treating the Metabolic Syndrome by Fecal Transplantation—Current Status. Biology 2021; 10(5): 447 doi: 10.3390/biology10050447
|
| 23 |
Stefan Hanf, Timea Bögözi, Robert Keiner, Torsten Frosch, Jürgen Popp. Fast and Highly Sensitive Fiber-Enhanced Raman Spectroscopic Monitoring of Molecular H2 and CH4 for Point-of-Care Diagnosis of Malabsorption Disorders in Exhaled Human Breath. Analytical Chemistry 2015; 87(2): 982 doi: 10.1021/ac503450y
|
| 24 |
Alessandra Lo Presti, Francesca Zorzi, Federica Del Chierico, Annamaria Altomare, Silvia Cocca, Alessandra Avola, Fabiola De Biasio, Alessandra Russo, Eleonora Cella, Sofia Reddel, Emma Calabrese, Livia Biancone, Giovanni Monteleone, Michele Cicala, Silvia Angeletti, Massimo Ciccozzi, Lorenza Putignani, Michele Pier Luca Guarino. Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01655
|
| 25 |
Gourab Dutta Banik, Anulekha De, Suman Som, Subhra Jana, Sunil B Daschakraborty, Sujit Chaudhuri, Manik Pradhan. Hydrogen sulphide in exhaled breath: a potential biomarker for small intestinal bacterial overgrowth in IBS. Journal of Breath Research 2016; 10(2): 026010 doi: 10.1088/1752-7155/10/2/026010
|
| 26 |
Kang-Qi Wu, Wen-Jing Sun, Ning Li, Yu-Qin Chen, Yan-Ling Wei, Dong-Feng Chen. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance. Scandinavian Journal of Gastroenterology 2019; 54(12): 1419 doi: 10.1080/00365521.2019.1694067
|
| 27 |
Charlotte K. Pitcher, Adam D. Farmer, Jordan J. Haworth, Sam Treadway, Anthony R. Hobson. Performance and Interpretation of Hydrogen and Methane Breath Testing Impact of North American Consensus Guidelines. Digestive Diseases and Sciences 2022; 67(12): 5571 doi: 10.1007/s10620-022-07487-8
|
| 28 |
Fanny Giron, Eamonn M M Quigley. Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective. Journal of Neurogastroenterology and Motility 2018; 24(3): 355 doi: 10.5056/jnm18004
|
| 29 |
Kok‐Ann Gwee, Uday Chand Ghoshal, Minhu Chen. Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management. Journal of Gastroenterology and Hepatology 2018; 33(1): 99 doi: 10.1111/jgh.13987
|
| 30 |
Wei Jia, Cynthia Rajani. Nutrition in the Prevention and Treatment of Disease. 2017; : 835 doi: 10.1016/B978-0-12-802928-2.00038-2
|
| 31 |
Qinghua Sun, Qiong Jia, Lijin Song, Liping Duan. Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome. Medicine 2019; 98(7): e14513 doi: 10.1097/MD.0000000000014513
|
| 32 |
David Willis, Donnie Cameron, Bahman Kasmai, Vassilios S. Vassiliou, Paul N. Malcolm, Gabriella Baio. A novel method for measuring bowel motility and velocity with dynamic magnetic resonance imaging in two and three dimensions. NMR in Biomedicine 2022; 35(5) doi: 10.1002/nbm.4663
|
| 33 |
Tarek Mazzawi. Gut Microbiota Manipulation in Irritable Bowel Syndrome. Microorganisms 2022; 10(7): 1332 doi: 10.3390/microorganisms10071332
|
| 34 |
Brooks D. Cash, Brian E. Lacy, Tharaknath Rao, David L. Earnest. Rifaximin and eluxadoline — newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?. Expert Opinion on Pharmacotherapy 2016; 17(3): 311 doi: 10.1517/14656566.2016.1118052
|
| 35 |
Hai-Ning Liu, Hao Wu, Yu-Zhuo Chen, Yan-Jie Chen, Xi-Zhong Shen, Tao-Tao Liu. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. Digestive and Liver Disease 2017; 49(4): 331 doi: 10.1016/j.dld.2017.01.142
|
| 36 |
Binrui Chen, John Jae-Woo Kim, Yawen Zhang, Lijun Du, Ning Dai. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis. Journal of Gastroenterology 2018; 53(7): 807 doi: 10.1007/s00535-018-1476-9
|
| 37 |
Sofia D. Shaikh, Natalie Sun, Andrew Canakis, William Y. Park, Horst Christian Weber. Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review. Journal of Clinical Medicine 2023; 12(7): 2558 doi: 10.3390/jcm12072558
|
| 38 |
Gourab D. Banik, Abhijit Maity, Suman Som, Chiranjit Ghosh, Sunil B. Daschakraborty, Sujit Chaudhuri, Shibendu Ghosh, Manik Pradhan. Diagnosis of small intestinal bacterial overgrowth in irritable bowel syndrome patients using high-precision stable13CO2/12CO2isotope ratios in exhaled breath. J. Anal. At. Spectrom. 2014; 29(10): 1918 doi: 10.1039/C4JA00186A
|
| 39 |
John Richard Thompson. Is irritable bowel syndrome an infectious disease?. World Journal of Gastroenterology 2016; 22(4): 1331-1334 doi: 10.3748/wjg.v22.i4.1331
|
| 40 |
Emidio Scarpellini, Lucrezia Laterza, Gianluca Ianiro, Jan Tack, Ludovico Abenavoli, Antonio Gasbarrini. Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 2016; 17(10): 1395 doi: 10.1080/14656566.2016.1182982
|
| 41 |
Sara Iqbal, Eamonn M. M. Quigley. Progress in Our Understanding of the Gut Microbiome: Implications for the Clinician. Current Gastroenterology Reports 2016; 18(9) doi: 10.1007/s11894-016-0524-y
|
| 42 |
Wojciech Marlicz, Diana E Yung, Karolina Skonieczna-Żydecka, Igor Loniewski, Saskia van Hemert, Beata Loniewska, Anastasios Koulaouzidis. From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases. Expert Review of Gastroenterology & Hepatology 2017; 11(10): 961 doi: 10.1080/17474124.2017.1343664
|
| 43 |
Jing Sun, Mengqiu Zhang, Wei Liu, Youqian Liu, Dongjian Zhang, Xinyu Fan, Jian Zhang, Tian Li, Min Lu. Evaluation of the effectiveness and mechanism of action of the Chang-Kang-Fang formula combined with bifid triple viable capsules on diarrhea-predominant irritable bowel syndrome. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1160783
|
| 44 |
Hyo Jeong Lee, Jong Kyoung Choi, Han Seung Ryu, Chang Hwan Choi, Eun Hee Kang, Kyung Sik Park, Yang Won Min, Kyoung Sup Hong. Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. Journal of Neurogastroenterology and Motility 2017; 23(1): 9 doi: 10.5056/jnm16124
|
| 45 |
Emelia Kay, Sham Hawramee, Stephen Pollani, Ellen D. Mandel. Nonpharmacologic options for treating irritable bowel syndrome. JAAPA 2019; 32(3): 38 doi: 10.1097/01.JAA.0000553384.82884.b8
|
| 46 |
Neha Garg, Srikanta Basu, Preeti Singh, Ruchika Kumar, Lokesh Sharma, Praveen Kumar. Prevalence of abnormal lactose breath hydrogen tests in children with functional abdominal pain. Indian Journal of Gastroenterology 2017; 36(3): 179 doi: 10.1007/s12664-017-0750-8
|
| 47 |
Uday C. Ghoshal, Deepakshi Srivastava, Asha Misra, Ujjala Ghoshal. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth. European Journal of Gastroenterology & Hepatology 2016; 28(3): 281 doi: 10.1097/MEG.0000000000000557
|
| 48 |
Uday C. Ghoshal, Sanjeev Sachdeva, Ujjala Ghoshal, Asha Misra, Amarender Singh Puri, Nitesh Pratap, Ayesha Shah, M. Masudur Rahman, Kok Ann Gwee, Victoria P Y Tan, Tahmeed Ahmed, Yeong Yeh Lee, B S Ramakrishna, Rupjyoti Talukdar, S V Rana, Saroj K Sinha, Minhu Chen, Nayoung Kim, Gerald Holtmann. Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association. Indian Journal of Gastroenterology 2022; 41(5): 483 doi: 10.1007/s12664-022-01292-x
|
| 49 |
Sodaif Darvishmoghadam, Mehdi Ansari, Habibeh Ahmadipour, Mahnaz Azimipour, Maria Esmaeilzade, Mohammad Javad Zahedi, Mehdi Hayat Bakhsh Abbasi, Bijan Ahmadi, Amir Asadi, Fariba Sharififar. Assessment of the effect of sachet formulation of almond (Amygdalus dulcis L.) on diarrhea prominent irritable bowel syndrome (IBS-D) symptoms: A clinical trial. Complementary Therapies in Medicine 2019; 45: 242 doi: 10.1016/j.ctim.2019.07.001
|
| 50 |
Weijie Yu, Shimeng Mou, Yingying Xue, Hangming Xiong, Yanjie Hu, Hao Wan, Ping Wang. Smart Electronic Nose for the Detection of Exhaled Breath to Diagnose Small Intestinal Bacterial Overgrowth. 2022 IEEE International Symposium on Olfaction and Electronic Nose (ISOEN) 2022; : 1 doi: 10.1109/ISOEN54820.2022.9789641
|
| 51 |
Uday C. Ghoshal, Kok-Ann Gwee. Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link. Nature Reviews Gastroenterology & Hepatology 2017; 14(7): 435 doi: 10.1038/nrgastro.2017.37
|
| 52 |
Yasutada Akiba, Koji Maruta, Kazuyuki Narimatsu, Hyder Said, Izumi Kaji, Ayaka Kuri, Ken-ichi Iwamoto, Atsukazu Kuwahara, Jonathan D. Kaunitz. FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 313(2): G117 doi: 10.1152/ajpgi.00041.2017
|
| 53 |
David Avelar Rodriguez, Paul MacDaragh Ryan, Erick Manuel Toro Monjaraz, Jaime Alfonso Ramirez Mayans, Eamonn Martin Quigley. Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review. Frontiers in Pediatrics 2019; 7 doi: 10.3389/fped.2019.00363
|
| 54 |
Rajan Singh, Hannah Zogg, Lai Wei, Allison Bartlett, Uday C Ghoshal, Singh Rajender, Seungil Ro. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders. Journal of Neurogastroenterology and Motility 2021; 27(1): 19 doi: 10.5056/jnm20149
|
| 55 |
Bryan Zoll, Nitin K. Ahuja. Nutritional Therapies for Irritable Bowel Syndrome: a Focus on Prebiotics and Probiotics. Current Treatment Options in Gastroenterology 2020; 18(4): 729 doi: 10.1007/s11938-020-00320-z
|
| 56 |
K. V. Ivashkin, V. R. Grechishnikova, M. S. Reshetova, V. T. Ivashkin. Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 31(1): 54 doi: 10.22416/1382-4376-2021-31-1-54-63
|
| 57 |
Qiao-Li Jiang, You Lu, Meng-Jie Zhang, Zhen-Yu Cui, Zhong-Mei Pei, Wen-Hua Li, Lun-Gen Lu, Jing-Jing Wang, Ying-Ying Lu. Mucosal bacterial dysbiosis in patients with nodular lymphoid hyperplasia in the terminal ileum. World Journal of Gastroenterology 2022; 28(8): 811-824 doi: 10.3748/wjg.v28.i8.811
|
| 58 |
Shino Shimura, Norihisa Ishimura, Hironobu Mikami, Eiko Okimoto, Goichi Uno, Yuji Tamagawa, Masahito Aimi, Naoki Oshima, Shuichi Sato, Shunji Ishihara, Yoshikazu Kinoshita. Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders. Journal of Neurogastroenterology and Motility 2015; 22(1): 60 doi: 10.5056/jnm15116
|
| 59 |
Hazel M. Ní Chonchubhair, Yasir Bashir, Mark Dobson, Barbara M. Ryan, Sinead N. Duggan, Kevin C. Conlon. The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI). Pancreatology 2018; 18(4): 379 doi: 10.1016/j.pan.2018.02.010
|
| 60 |
Kamesh Gupta, Harparam Singh Ghuman, Shivani Vijay Handa. Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile. Clinical Medicine Insights: Gastroenterology 2017; 10: 117955221772890 doi: 10.1177/1179552217728905
|
| 61 |
Xiaojun Zhuang, Lishou Xiong, Li Li, Manying Li, Minhu Chen. Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2017; 32(1): 28 doi: 10.1111/jgh.13471
|
| 62 |
|
| 63 |
A. V. Nalyotov, N. P. Guz. Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Irritable Bowel Syndrome who Have Suffered COVID-19. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(3): 35 doi: 10.22416/1382-4376-2022-32-3-35-39
|
| 64 |
Pelagia-Irene Gouma, Fateh Mikaeili, Jusang Lee, Yasha Karimi, Milutin Stancevic. Sensing device for breath biomarker detection. 2019 IEEE International Symposium on Olfaction and Electronic Nose (ISOEN) 2019; : 1 doi: 10.1109/ISOEN.2019.8823354
|
| 65 |
Yasutada Akiba, Takuya Inoue, Izumi Kaji, Masaaki Higashiyama, Kazuyuki Narimatsu, Ken‐ichi Iwamoto, Masahiko Watanabe, Paul H. Guth, Eli Engel, Atsukazu Kuwahara, Jonathan D Kaunitz. Short‐chain fatty acid sensing in rat duodenum. The Journal of Physiology 2015; 593(3): 585 doi: 10.1113/jphysiol.2014.280792
|
| 66 |
Hua Chu, Mark Fox, Xia Zheng, Yanyong Deng, Yanqin Long, Zhihui Huang, Lijun Du, Fei Xu, Ning Dai. Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/3230859
|
| 67 |
Chang Hwan Choi, Sae Kyung Chang. Role of Small Intestinal Bacterial Overgrowth in Functional Gastrointestinal Disorders. Journal of Neurogastroenterology and Motility 2015; 22(1): 3 doi: 10.5056/jnm15196
|
| 68 |
Shahnaz Mohammadi, Maryam Izadi-Mazi, Mahsa Akbarian-F. Anxiety and Quality of Life in patients with Irritable Bowel Syndrome. Journal of Medical Sciences 2015; 15(5): 235 doi: 10.3923/jms.2015.235.240
|
| 69 |
David Avelar Rodriguez, Paul MacDaragh Ryan, Eamonn Martin Mary Quigley. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. 2022; : 567 doi: 10.1007/978-3-030-80068-0_42
|
| 70 |
Ana M González‐Castro, Cristina Martínez, Eloísa Salvo‐Romero, Marina Fortea, Cristina Pardo‐Camacho, Teresa Pérez‐Berezo, Carmen Alonso‐Cotoner, Javier Santos, María Vicario. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome. Journal of Gastroenterology and Hepatology 2017; 32(1): 53 doi: 10.1111/jgh.13417
|
| 71 |
Tarek Mazzawi, Gülen Arslan Lied, Dag André Sangnes, Magdy El-Salhy, Johannes R. Hov, Odd Helge Gilja, Jan Gunnar Hatlebakk, Trygve Hausken, John Green. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation. PLOS ONE 2018; 13(11): e0194904 doi: 10.1371/journal.pone.0194904
|
| 72 |
Andrés Acosta, Michael Camilleri, Andrea Shin, Sara Linker Nord, Jessica O'Neill, Amber V Gray, Alan J Lueke, Leslie J Donato, Duane D Burton, Lawrence A Szarka, Alan R Zinsmeister, Pamela L Golden, Anthony Fodor. Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. Clinical and Translational Gastroenterology 2016; 7(5): e173 doi: 10.1038/ctg.2016.32
|
| 73 |
Xiaojun Zhuang, Zhenyi Tian, Mei Luo, Lishou Xiong. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01336-6
|